| # | Drug | Count |
|---|---|---|
| 0 | LENALIDOMIDE | 406 |
| 1 | DEXAMETHASONE | 380 |
| 2 | DEXAMETHASONE 1.5 MG | 375 |
| 3 | CYCLOPHOSPHAMIDE | 348 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 348 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 348 |
| 6 | METHOTREXATE SODIUM | 327 |
| 7 | METHOTREXATE | 289 |
| 8 | BLINATUMOMAB | 247 |
| 9 | CYTARABINE | 205 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TITANIUM DIOXIDE,ZINC OXIDE | 2 | 0.0541 |
| 1 | ATORVALIQ | 1 | 0.0500 |
| 2 | BLINATUMOMAB | 247 | 0.0238 |
| 3 | TISAGENLECLEUCEL | 102 | 0.0224 |
| 4 | INOTUZUMAB OZOGAMICIN | 45 | 0.0153 |
| 5 | PONATINIB HYDROCHLORIDE | 72 | 0.0139 |
| 6 | CLOFARABINE | 27 | 0.0119 |
| 7 | FLUORIDE TOOTHPASTE | 2 | 0.0099 |
| 8 | NELARABINE | 8 | 0.0084 |
| 9 | DEFIBROTIDE SODIUM | 28 | 0.0079 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 608 |
| 1 | Alkylating Drug [EPC] | 419 |
| 2 | Thalidomide Analog [EPC] | 415 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 288 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 285 |
| 5 | Azole Antifungal [EPC] | 171 |
| 6 | Proteasome Inhibitor [EPC] | 160 |
| 7 | Topoisomerase Inhibitor [EPC] | 141 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 131 |
| 9 | Platinum-based Drug [EPC] | 109 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 45 | 0.0153 |
| 1 | CD19-directed Chimeric Antigen Receptor [EPC] | 103 | 0.0072 |
| 2 | Interleukin-6 Antagonist [EPC] | 4 | 0.0063 |
| 3 | Actinomycin [EPC] | 9 | 0.0041 |
| 4 | Vasoconstrictor [EPC] | 1 | 0.0034 |
| 5 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 6 | Hematopoietic Stem Cell Mobilizer [EPC] | 3 | 0.0020 |
| 7 | Echinocandin Antifungal [EPC] | 16 | 0.0020 |
| 8 | Topoisomerase Inhibitor [EPC] | 141 | 0.0018 |
| 9 | Alkylating Drug [EPC] | 419 | 0.0017 |